United Services Automobile Association G1 Therapeutics, Inc. Transaction History

United Services Automobile Association

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2019 Nov 13, 2019	SELL	$22.78 - $40.58 $2.14 Million - $3.81 Million	-93,882 Closed	0 $0
Q2 2019 Aug 16, 2019	BUY	$16.03 - $31.1 $185,948 - $360,760	11,600 Added 14.1%	93,882 $2.88 Million
Q1 2019 May 13, 2019	BUY	$14.4 - $21.45 $204,897 - $305,212	14,229 Added 20.91%	82,282 $1.37 Million
Q4 2018 Feb 13, 2019	SELL	$16.51 - $51.33 $71,735 - $223,028	-4,345 Reduced 6.0%	68,053 $1.3 Million
Q3 2018 Nov 13, 2018	BUY	$43.15 - $67.97 $73,527 - $115,820	1,704 Added 2.41%	72,398 $3.79 Million
Q2 2018 Aug 10, 2018	BUY	$35.06 - $51.17 $65,982 - $96,301	1,882 Added 2.73%	70,694 $3.07 Million
Q1 2018 May 14, 2018	BUY	$19.05 - $41.76 $1.31 Million - $2.87 Million	68,812 New	68,812 $2.55 Million

3.55M

11.7K

Ticker GTHX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 42,746,800
Market Cap $306M
Description
G1 Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in the discovery, development, and commercialization of small molecule therapeutics for the treatment of patients with cancer. The company offers COSELA, which helps to decrease chemotherapy-induced myelosuppression in adult patients when administered prior to a platinum/...

Get notified when there are updates to the investment portfolio of United Services Automobile Association, based on Form 13F filings with the SEC.

Stay updated on United Services Automobile Association with notifications on news.